[Federal Register Volume 87, Number 213 (Friday, November 4, 2022)]
[Notices]
[Pages 66747-66748]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-24103]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1099]


Bulk Manufacturer of Controlled Substances Application: Organix 
Chemistry Solutions LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Organix Chemistry Solutions LLC, has applied to be registered 
as a bulk manufacturer of basic class(es) of controlled substance(s). 
Refer to SUPPLEMENTARY INFORMATION listed below for further drug 
information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit

[[Page 66748]]

electronic comments on or objections to the issuance of the proposed 
registration on or before January 3, 2023. Such persons may also file a 
written request for a hearing on the application on or before January 
3, 2023.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on September 26, 2022, Organix Chemistry Solutions LLC, 
240 Salem Street, Woburn, Massachusetts 01801-2029, applied to be 
registered as a bulk manufacturer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
           Controlled substance               Drug code       Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid................            2010  I
Lysergic acid diethylamide...............            7315  I
Marihuana................................            7360  I
Tetrahydrocannabinols....................            7370  I
Mescaline................................            7381  I
3,4,5- Trimethoxyamphetamine.............            7390  I
4-Bromo-2,5-dimethoxyphenethylamine......            7392  I
3,4-Methylenedioxyamphetamine............            7400  I
3,4-Methylenedioxymethamphetamine........            7405  I
5-Methoxy-N-N-dimethyltryptamine.........            7431  I
Alpha-Methyltryptamine...................            7432  I
Bufotenine...............................            7433  I
Diethyltryptamine........................            7434  I
Dimethyltryptamine.......................            7435  I
Psilocybin...............................            7437  I
Psilocyn.................................            7438  I
2-(2,5-Dimethoxy-4-methylphenyl)                     7508  I
 ethanamine (2C-D).
2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)            7517  I
2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine            7518  I
 (2C-I).
Heroin...................................            9200  I
Morphine.................................            9300  II
------------------------------------------------------------------------

    The company plans to synthesize the above listed controlled 
substances for distribution to its customers. In reference to dug codes 
7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans 
to bulk manufacture these drugs as synthetic. No other activities for 
these drug codes are authorized for this registration.

Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-24103 Filed 11-3-22; 8:45 am]
BILLING CODE P